Ivan P. Gergel, SVP & Chief Medical Officer at NEKTAR THERAPEUTICS (NKTR), sold 54,920 shares at $21.10 ($1.2M) on 2017-07-18, disclosed to the SEC on 2017-07-20.
Open-market sale of $1.2M NKTR by SVP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NKTR | SELL | 2017-07-13 | $1.9M | — | Filing → |
| NKTR | SELL | 2017-05-18 | $28K | — | Filing → |
| NKTR | SELL | 2017-02-17 | $19K | — | Filing → |